Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial
与阿仑膦酸钠相比,罗莫索单抗可改善绝经后妇女的腰椎骨量和骨强度参数:来自高危骨质疏松症绝经后妇女主动对照骨折研究(ARCH)试验的结果
期刊:Journal of Bone and Mineral Research
影响因子:5.9
doi:10.1002/jbmr.4409
Brown, Jacques P; Engelke, Klaus; Keaveny, Tony M; Chines, Arkadi; Chapurlat, Roland; Foldes, A Joseph; Nogues, Xavier; Civitelli, Roberto; De Villiers, Tobias; Massari, Fabio; Zerbini, Cristiano A F; Wang, Zhenxun; Oates, Mary K; Recknor, Christopher; Libanati, Cesar